Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance

Health and Human Services Department; Food and Drug Administration · 2011

Read Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-12624.txt.

Description

Notice published in the Federal Register on 2011-05-24 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [FR Doc No: 2011-12624] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2001-D-0066] (Formerly Docket No. 2001D-0107) Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance AGENCY: Food and Drug Administration, HHS. ACTION: Notice; withdrawal. ----------------------------------------------------------------------- SUMMARY:.

Catalog record

CREATORHealth and Human Services Department; Food and Drug Administration
YEAR2011
COLLECTIONLAW
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEFederal Register

Source: https://www.federalregister.gov/documents/2011/05/24/2011-12624/expedited-review-for-new-animal-drug-applications-for-human-pathogen-reduction-claims-withdrawal-of

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance
Citation: us:fr:2011-12624
Creator: Health and Human Services Department; Food and Drug Administration
Year: 2011
Source-URL: https://www.federalregister.gov/documents/2011/05/24/2011-12624/expedited-review-for-new-animal-drug-applications-for-human-pathogen-reduction-claims-withdrawal-of
Context: Notice published in the Federal Register on 2011-05-24 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo).

[FR Doc No: 2011-12624]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2001-D-0066] (Formerly Docket No. 2001D-0107)


Expedited Review for New Animal Drug Applications for Human 
Pathogen Reduction Claims; Withdrawal of Guidance

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of a guidance that was issued on March 9, 2001.

DATES: May 24, 2011.

FOR FURTHER INFORMATION CONTACT:  Steven Vaughn, Center for Veterinary 
Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., 
Rockville, MD 20855, 240-276-8300.

SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
Register of March 9, 2001 (66 FR 14155), FDA announced the availability 
of a guidance for industry 121 entitled ``Expedited Review for 
New Animal Drug Applications for Human Pathogen Reduction Claims.''
    The guidance predates the enactment of the Animal Drug User Fee Act 
(ADUFA) of 2003, which was reauthorized by Congress in 2008. ADUFA 
authorized FDA to collect fees for certain animal drug applications and 
for the establishments, products, and sponsors associated with these 
and previously approved animal drug applications, in support of the 
review of animal drug products. As a result of these increased 
resources, the efficiencies of our current administrative processes, 
including the phased review and end review amendment processes, we have 
significantly reduced our review timeframes and afford sponsors a more 
efficient pathway to regulatory approval.
    At the time the guidance was issued, FDA's review timeframes for 
new animal drug applications were considerably longer. As noted 
previously, significant changes have occurred in the Agency's processes 
and timeframes for reviewing new animal drug applications and the 
process for expedited review status contained in this guidance is 
outdated and no longer needed to assure the efficient review of these 
new animal drug applications.

    Dated: May 4, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-12624 Filed 5-23-11; 8:45 am]

Read the complete text